- Consistently positive technical signals over the last month
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Trading above its 200-day moving average
Volatile ride for Lantern Pharma Inc. stock price on Thursday moving between $3.55 and $4.09
(Updated on Jun 25, 2026)
The Lantern Pharma Inc. stock price fell by -7.09% on the last day (Thursday, 25th Jun 2026) from $3.95 to $3.67. During the last trading day the stock fluctuated 15.21% from a day low at $3.55 to a day high of $4.09. The price has fallen in 6 of the last 10 days and is down by -5.41% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -109 thousand shares and in total, 187 thousand shares were bought and sold for approximately $687.79 thousand.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 141.71% during the next 3 months and, with a 90% probability hold a price between $8.03 and $10.75 at the end of this 3-month period.
LTRN Signals & Forecast
The Lantern Pharma Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.85. On a fall, the stock will find some support from the long-term average at approximately $3.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -9.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Lantern Pharma Inc. stock
Lantern Pharma Inc. finds support from accumulated volume at $3.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.540 between high and low, or 15.21%. For the last week the stock has had daily average volatility of 7.73%.
Our recommended stop-loss: $3.45 (-6.06%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 9 days ago.)
Trading Expectations (LTRN) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Lantern Pharma Inc. to open at $3.77, and during the day (based on 14 day Average True Range), to move between $3.50 and $3.84, which gives a possible trading interval of +/-$0.345 (+/-9.88%) up or down from last closing price. If Lantern Pharma Inc. takes out the full calculated possible swing range there will be an estimated 9.88% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $3.74 (1.91%) than the support at $3.50 (4.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Lantern Pharma Inc. stock A Buy?
Lantern Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.
Current score:
0.939
Hold/Accumulate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 26, 2026 - $3.77 ( 2.72%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
LTRN Performance
Trading levels for LTRN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.31 | 17.44% |
| R2 | 4.10 | 11.82% |
| R1 | 3.98 | 8.35% |
| Price | 3.67 | |
| S1 | 3.56 | -2.90% |
| S2 | 3.44 | -6.37% |
| S3 | 3.23 | -11.99% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 3.88 | 5.72% |
| R2 | 3.79 | 3.27% |
| R1 | 3.74 | 1.91% |
| Price | 3.67 | |
| S1 | 3.50 | -4.63% |
| S2 | 3.14 | -14.44% |
| S3 | 3.13 | -14.71% |
FAQ
Click here for our free guide on how to buy Lantern Pharma Inc. Stock.
Buy LTRN